| Application no. and date | 13155091.5 (espacenet) (Federated) (European Patent Register), 20060302 | | Patent/reg. no. and date | DK/EP 2620450, 20181107 | | Publication date | 20130731 | | Priority no. and date | US 659766 P, 20050308, US 728165 P, 20051019, US 752712 P, 20051220, US 762456 P, 20060126 | | EP pub. no. and date |
EP 2620450 20130731 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340, US | | Applicant ref. no. | SH/GP/157820 | | Inventor | Abate, Justin Donald, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US,
Das, Tapan Kanti, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US,
Elliott, Carrie Marie, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US,
Muthurania, Kevin Wamiti, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US,
Nema, Sandeep, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US,
Singh, Satish Kumar, c/o Pfizer Global Res. & Dev.
700 Chesterfield Parkway West
Chesterfield, MO 63017, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | Antistofsammensætninger mod CTLA-4 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2023 00023 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
